Scientists used human brain organoids to study the mechanisms underlying microcephaly caused by Zika virus and herpes simplex virus.
[Cell Stem Cell]
6445218 A299ZW6P items 1 apa default asc 1
Krenn, V., Bosone, C., Burkard, T. R., Spanier, J., Kalinke, U., Calistri, A., Salata, C., Christoff, R. R., Garcez, P. P., Mirazimi, A., & Knoblich, J. A. (2021). Organoid modeling of Zika and herpes simplex virus 1 infections reveals virus-specific responses leading to microcephaly. Cell Stem Cell, 0(0). https://doi.org/10.1016/j.stem.2021.03.004 Cite
Volastra Therapeutics announced it will collaborate with Microsoft to develop tools that help detect drivers of cancer metastasis. The collaboration will develop automated machine learning tools capable of rapidly and accurately integrating insights across multiple datasets, including pathology slides and 3D tumor-derived organoids.
[Volastra Therapeutics (BusinessWire, Inc.)]
6445218 nan items 1 apa default asc 1
The authors present a protocol to establish a novel human retinoblastoma organoid model derived from genetically engineered human embryonic stem cells.
Scientists succinctly illustrate the three technologies that are closer to clinical translation—namely, human intestinal organoids, sphincter bioengineering and decellularization
6445218 AU2AGHRN items 1 apa default asc 1
Scientists provide a step-by-step protocol for generating fused forebrain organoids derived from human pluripotent stem cells.
Patient-derived organoids (PDOs) from human tissue samples allow for unique and faithful in vitro modeling of esophageal cancers, and provide an exciting platform for investigation into personalized medicine and targeted treatment approaches
6445218 BL6TEXCY items 1 apa default asc 1
Using single‐cell RNA sequencing, researchers explored the transcriptional landscape of a murine organoid model of hereditary diffuse gastric cancer to characterize the impact of CDH1 loss in early tumorigenesis.
[Journal of Pathology]
6445218 CKHSEIPD items 1 apa default asc 1
Dixon, K., Brew, T., Farnell, D., Godwin, T. D., Cheung, S., Chow, C., Ta, M., Ho, G., Bui, M., Douglas, J. M., Campbell, K. R., El‐Naggar, A., Kaurah, P., Kalloger, S. E., Lim, H. J., Schaeffer, D. F., Cochrane, D., Guilford, P., & Huntsman, D. G. (n.d.). Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing. The Journal of Pathology, n/a(n/a). https://doi.org/https://doi.org/10.1002/path.5675 Cite
Scientists demonstrated the enhanced anti-cancer activity between two botanical extracts in terms of their ability to inhibit cancer cell growth, suppress colony formation and induce apoptosis. They validated these findings in subcutaneous xenograft models and in patient derived primary epithelial 3D organoids.
6445218 PSP7N3EF items 1 apa default asc 1
Shimura, T., Sharma, P., Sharma, G. G., Banwait, J. K., & Goel, A. (2021). Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer. Scientific Reports, 11(1), 7548. https://doi.org/10.1038/s41598-021-87283-y Cite
Researchers found an increase in ADCK1 (AarF domain-containing kinase 1) expression in clinical specimens of colon cancer and animal models. Downregulation of ADCK1 expression inhibited the colony formation and infiltration of cancer cells, in vivo tumorigenesis, migration, and organoid formation.
[Cell Death & Disease]
6445218 2F89HQMN items 1 apa default asc 1
Ji, Y., Liu, Y., Sun, C., Yu, L., Wang, Z., Du, X., Yang, W., Zhang, C., Tao, C., Wang, J., Yang, X., Di, S., & Huang, Y. (2021). ADCK1 activates the β-catenin/TCF signaling pathway to promote the growth and migration of colon cancer cells. Cell Death & Disease, 12(4), 1–12. https://doi.org/10.1038/s41419-021-03624-9 Cite
Scientists identified preoperative plasma protein biomarkers with the potential to predict early recurrence after resection of PDAC.
6807162 NQDHEG3X items 1 apa default asc 1
Rittmann, M.-C., Hussung, S., Braun, L. M., Klar, R. F. U., Biesel, E. A., Fichtner-Feigl, S., Fritsch, R., Wittel, U. A., & Ruess, D. A. (2021). Plasma biomarkers for prediction of early tumor recurrence after resection of pancreatic ductal adenocarcinoma. Scientific Reports, 11(1), 7499. https://doi.org/10.1038/s41598-021-86779-x Cite
Personalized medicine research for aggressive abdominal cancers at Wake Forest Baptist Health received a boost from a $2.5 million grant from the National Cancer Institute that supports research efforts at Wake Forest Organoid Research Center.
[Wake Forest Baptist Health (Newswise, Inc.)]
6445218 nan items 1 apa default asc 1